{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:15:08Z","timestamp":1773299708595,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.cll.2006.06.004","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:29:29Z","timestamp":1168439369000},"page":"571-590","source":"Crossref","is-referenced-by-count":43,"title":["Measures of Oxidative Stress"],"prefix":"10.1016","volume":"26","author":[{"given":"Sotirios","family":"Tsimikas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2006.06.004_bib1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMp038136","article-title":"Novel risk markers and clinical practice","volume":"349","author":"Manolio","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2006.06.004_bib2","first-page":"385","article-title":"Lipoproteins, lipoprotein oxidation and atherogenesis. Molecular basis of cardiovascular disease. A companion to Braunwald's heart disease","author":"Tsimikas","year":"2004"},{"key":"10.1016\/j.cll.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis: the oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cll.2006.06.004_bib4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.103.15.1930","article-title":"Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk","volume":"103","author":"Tsimikas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI5897","article-title":"Disruption of the 12\/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice","volume":"103","author":"Cyrus","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.RES.0000163631.07205.fb","article-title":"NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease","volume":"96","author":"Cai","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cll.2006.06.004_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/01.ATV.0000135267.82813.52","article-title":"Myeloperoxidase and plaque vulnerability","volume":"24","author":"Hazen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-006-0065-1","article-title":"Oxidized low-density lipoprotein biomarkers in atherosclerosis","volume":"8","author":"Tsimikas","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cll.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.ATV.20.3.689","article-title":"In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression","volume":"20","author":"Tsimikas","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib10","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1096\/fj.02-0226rev","article-title":"The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis","volume":"16","author":"Palinski","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.cll.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.ATV.0000149378.98458.fe","article-title":"Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization","volume":"24","author":"Torzewski","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000028465.52694.9B","article-title":"Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma","volume":"106","author":"Aikawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cll.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI117963","article-title":"Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease","volume":"95","author":"Holvoet","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-2275(20)37634-3","article-title":"Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody","volume":"37","author":"Itabe","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cll.2006.06.004_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1172\/JCI118853","article-title":"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma","volume":"98","author":"Palinski","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib18","doi-asserted-by":"crossref","first-page":"15274","DOI":"10.1016\/S0021-9258(17)36602-4","article-title":"A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides","volume":"269","author":"Itabe","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2006.06.004_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"H\u00f6rkk\u00f6","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0038-1650639","article-title":"Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure","volume":"76","author":"Holvoet","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cll.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.ATV.20.3.698","article-title":"Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease","volume":"20","author":"Holvoet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.ATV.18.6.884","article-title":"An animal model to study local oxidation of LDL and its biological effects in the arterial wall","volume":"18","author":"Calara","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib23","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/S0021-9258(18)52241-9","article-title":"Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells","volume":"266","author":"Van Berkel","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0022-2275(20)30281-9","article-title":"Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein","volume":"42","author":"Gillotte-Taylor","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cll.2006.06.004_bib25","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1074\/jbc.M108860200","article-title":"Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids: importance of Schiff base formation and Aldol condensation","volume":"277","author":"Friedman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cll.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","article-title":"Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity","volume":"105","author":"Shaw","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/clinchem\/32.8.1484","article-title":"Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B","volume":"32","author":"Young","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","article-title":"Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes","volume":"41","author":"Tsimikas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib30","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib32","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.ATV.0000080379.05071.22","article-title":"Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body composition study","volume":"23","author":"Holvoet","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2796.2002.01054.x","article-title":"Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study)","volume":"252","author":"Sigurdardottir","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.cll.2006.06.004_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.ATV.0000021150.63480.CD","article-title":"Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study)","volume":"22","author":"Hulthe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib36","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.ATV.0000135982.60383.48","article-title":"Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families","volume":"24","author":"Liu","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib37","article-title":"Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of atherosclerotic disease","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib38","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","article-title":"Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: the effect of pravastatin","volume":"47","author":"Rodenburg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2006.06.004_bib40","first-page":"e71","article-title":"A possible novel function for lipoprotein(a) as a carrier of oxidized phospholipids","volume":"25","author":"Bergmark","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-8981(02)00103-1","article-title":"Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects","volume":"321","author":"Kobayashi","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cll.2006.06.004_bib43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)01180-3","article-title":"Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein","volume":"37","author":"Penny","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jacc.2004.03.064","article-title":"Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin","volume":"44","author":"Matsumoto","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9150(00)00494-9","article-title":"Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina","volume":"154","author":"Kugiyama","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cll.2006.06.004_bib46","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.ATV.0000012351.63938.84","article-title":"Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles","volume":"22","author":"Tanaga","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib47","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/01.ATV.0000190675.08857.3d","article-title":"Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome","volume":"25","author":"Sjogren","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib48","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/01.CIR.0000129304.98566.D8","article-title":"Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness","volume":"109","author":"Jarvisalo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.ATV.0000118012.64932.f4","article-title":"Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a)","volume":"24","author":"Silaste","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib50","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.20.10.2243","article-title":"Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease","volume":"20","author":"Toshima","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","article-title":"Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease","volume":"21","author":"Holvoet","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib52","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jama.281.18.1718","article-title":"Malondialdehyde-modified LDL as a marker of acute coronary syndromes","volume":"281","author":"Holvoet","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cll.2006.06.004_bib53","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","article-title":"Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes","volume":"103","author":"Ehara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib54","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.ATV.0000033829.14012.18","article-title":"Oxidized LDL in carotid plaques and plasma associates with plaque instability","volume":"22","author":"Nishi","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2005.05.020","article-title":"Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques","volume":"185","author":"Anselmi","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cll.2006.06.004_bib56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ahj.2004.12.008","article-title":"Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina","volume":"150","author":"Segev","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cll.2006.06.004_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ahj.2004.10.008","article-title":"Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting","volume":"150","author":"Braun","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cll.2006.06.004_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/01.ATV.0000209886.31510.7f","article-title":"Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis","volume":"26","author":"Naruko","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2796.2005.01484.x","article-title":"Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial","volume":"257","author":"Diepeveen","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.cll.2006.06.004_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cccn.2005.04.032","article-title":"Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease","volume":"360","author":"Ndrepepa","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cll.2006.06.004_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.atherosclerosis.2004.01.029","article-title":"Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease","volume":"174","author":"Shimada","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cll.2006.06.004_bib62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","article-title":"Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population","volume":"112","author":"Meisinger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2796.2004.01402.x","article-title":"Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men","volume":"256","author":"Wallenfeldt","year":"2004","journal-title":"J\u00a0Intern Med"},{"issue":"7","key":"10.1016\/j.cll.2006.06.004_bib64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","article-title":"The role of natural antibodies in atherogenesis","volume":"46","author":"Binder","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cll.2006.06.004_bib65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1179\/016164105X18395","article-title":"Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement","volume":"27","author":"Uno","year":"2005","journal-title":"Neurol Res"},{"key":"10.1016\/j.cll.2006.06.004_bib66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/jnnp.74.3.312","article-title":"Raised plasma oxidised LDL in acute cerebral infarction","volume":"74","author":"Uno","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cll.2006.06.004_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-002-0523-y","article-title":"Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease","volume":"104","author":"Dei","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.cll.2006.06.004_bib68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.ATV.18.1.100","article-title":"Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease","volume":"18","author":"Holvoet","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0735-1097(02)01721-7","article-title":"Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure","volume":"39","author":"Tsutsui","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib70","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.chemphyslip.2003.09.012","article-title":"F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases","volume":"128","author":"Pratico","year":"2004","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cll.2006.06.004_bib72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.ATV.0000152605.64964.c0","article-title":"Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans","volume":"25","author":"Morrow","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(99)00106-8","article-title":"Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress","volume":"300","author":"Morrow","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cll.2006.06.004_bib74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0891-5849(02)01018-3","article-title":"Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry","volume":"34","author":"Liang","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cll.2006.06.004_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1570-0232(03)00600-7","article-title":"Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry","volume":"796","author":"Bohnstedt","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cll.2006.06.004_bib76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1050-1738(01)00099-8","article-title":"Lipid peroxidation in mouse models of atherosclerosis","volume":"11","author":"Pratico","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cll.2006.06.004_bib77","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/2685","article-title":"Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice","volume":"4","author":"Pratic\u00f3","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.cll.2006.06.004_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1074\/jbc.M003324200","article-title":"Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E","volume":"276","author":"Tangirala","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cll.2006.06.004_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.V97.2.459","article-title":"Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E","volume":"97","author":"Pratico","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cll.2006.06.004_bib80","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.ATV.17.11.3230","article-title":"In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia","volume":"17","author":"Davi","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib81","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.98.25.2822","article-title":"Increased formation of distinct F2 isoprostanes in hypercholesterolemia","volume":"98","author":"Reilly","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib82","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.CIR.0000038500.43292.D7","article-title":"Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E","volume":"106","author":"De Caterina","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib83","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Davi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(95)00649-T","article-title":"Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus","volume":"368","author":"Gopaul","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cll.2006.06.004_bib85","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2006.06.004_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","article-title":"Modulation of oxidant stress in vivo in chronic cigarette smokers","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib87","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","article-title":"Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease","volume":"106","author":"Minuz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib88","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/hc3501.095287","article-title":"Oxidative stress and platelet activation in homozygous homocystinuria","volume":"104","author":"Davi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib89","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.ATV.19.5.1263","article-title":"Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels","volume":"19","author":"Voutilainen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib90","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI119735","article-title":"Localization of distinct F2-isoprostanes in human atherosclerotic lesions","volume":"100","author":"Pratico","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib91","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/01.ATV.17.11.3236","article-title":"Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions","volume":"17","author":"Gniwotta","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cll.2006.06.004_bib92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI3985","article-title":"The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis","volume":"103","author":"Mallat","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cll.2006.06.004_bib93","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.CIR.102.9.1007","article-title":"Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina","volume":"102","author":"Cipollone","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib94","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0735-1097(00)01040-8","article-title":"Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA","volume":"37","author":"Iuliano","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cll.2006.06.004_bib95","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1161\/01.CIR.96.10.3314","article-title":"Increased formation of the isoprostanes IPF2{alpha}-I and 8-epi-prostaglandin F2{alpha} in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans","volume":"96","author":"Reilly","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cll.2006.06.004_bib96","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.95.11.2492","article-title":"8-Epi PGF2{\u03b1} generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo","volume":"95","author":"Delanty","year":"1997","journal-title":"Circulation"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271206000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271206000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:02:53Z","timestamp":1628341373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271206000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0272271206000497"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2006.06.004","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}